Morningstar Investor users sign in here.

Company Profile

  • Business description

    Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

  • Contact

    Gottlieb-Daimler-Strabe 2
    Mannheim BW 68165
    DEU

    T: +49 621560030

    E: ir@affimed.com

    https://www.affimed.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    78

Stocks News & Analysis

stocks

Our only wide moat ASX miner is finally looking to expand

Is the proposed deal a winner for shareholders?
stocks

A 15 step checklist from Buffett's forgotten inspiration

Phil Fisher achieved remarkable stock market returns by holding high quality growth companies for long periods of time. Here's how he found them.
video

Are Guzman's growth targets realistic?

Morningstar Equity Analyst Lochlan Halloway discusses Guzman's upcoming IPO. 

Markets

Index
Last price
Change
% Change
All Ordinaries 7,960.80 14.00 -0.18%
CAC 40 7,503.27 204.75 -2.66%
DAX 40 18,002.02 263.66 -1.44%
Dow JONES (US) 38,589.16 57.94 -0.15%
FTSE 100 8,146.86 16.81 -0.21%
HKSE 17,978.30 36.52 0.20%
NASDAQ 17,688.88 21.32 0.12%
Nikkei 225 38,007.46 807.10 -2.08%
NZX 50 Index 11,700.20 164.69 -1.39%
S&P 500 5,431.60 2.14 -0.04%
S&P/ASX 200 7,717.40 6.90 -0.09%
SSE Composite Index 3,017.12 15.52 -0.51%

Market Movers

Name
Last price
Change
% Change
Peninsula Energy Ltd PEN 0.10 0.00 -2.38%
Pilbara Minerals Ltd PLS 3.14 0.10 -3.09%
Core Lithium Ltd CXO 0.09 0.01 -5.43%
Red 5 Ltd RED 0.46 0.01 2.81%
Sayona Mining Ltd SYA 0.04 0.00 -2.78%
Imugene Ltd IMU 0.06 0.00 -1.72%
Tabcorp Holdings Ltd TAH 0.67 0.01 1.91%
Droneshield Ltd DRO 1.44 0.02 -1.37%
Botanix Pharmaceuticals Ltd BOT 0.34 0.01 3.79%
De Grey Mining Ltd DEG 1.03 0.02 1.98%